Table 2.
Tumour characteristics in patients with hepatocellular carcinoma by Barcelona Clinic Liver Cancer (BCLC) stage at the index visit
| Tumour characteristics | BCLC stage | Total (n = 254) | P-valuea | ||||
|---|---|---|---|---|---|---|---|
| 0 (n = 8) | A (n = 76) | B (n = 105) | C (n = 48) | D (n = 17) | |||
| Number of lesions, n (%) | |||||||
| 1 | 8 (100%) | 49 (64.5%) | 31 (29.5%) | 24 (50.0%) | 7 (41.2%) | 119 (46.9%) | <0.0001 |
| 2 | 0 | 15 (19.7%) | 27 (25.7%) | 4 (8.3%) | 4 (23.5%) | 50 (19.7%) | |
| 3 | 0 | 11 (14.5%) | 19 (18.1%) | 3 (6.3%) | 2 (11.8%) | 36 (14.2%) | |
| 4 or 5 | 0 | 0 | 11 (10.5%) | 3 (6.3%) | 0 | 14 (5.5%) | |
| >5 | 0 | 0 | 17 (16.2%) | 14 (29.2%) | 4 (23.5%) | 35 (13.8%) | |
| Largest tumour size, median, cm | 1.5 | 2.7 | 5.0 | 6.9 | 4.6 | 4 | <0.0001 |
| <3 cm, n (%) | 7 (87.5%) | 57 (75%) | 14 (13.3%) | 5 (10.4%) | 6 (35.3%) | 89 (35.0%) | <0.0001 |
| 3–5 cm, n (%) | 1 (12.5%) | 18 (23.7%) | 41 (39.1%) | 10 (20.8%) | 3 (17.7%) | 73 (28.7%) | |
| >5 cm, n (%) | 0 | 1 (1.3%) | 50 (47.6%) | 33 (68.8%) | 8 (47.1%) | 92 (36.2%) | |
a
P-values were calculated using Fisher's exact test or chi-squared tests for categorical variables; continuous variables were rank-transformed.